InnovAge Holding Corp.: directors' dealings · United States · SEC (Form 4)

About InnovAge Holding Corp.

InnovAge Holding Corp. (Nasdaq: INNV) is a U.S.-listed healthcare company headquartered in Denver, Colorado, focused on serving frail older adults, especially dual-eligible seniors who qualify for both Medicaid and Medicare, through the PACE model (Program of All-inclusive Care for the Elderly). The company in its current for-profit form was established in 2016 to acquire the business of InnovAge, whose predecessor organization was formed in 2007; InnovAge went public in March 2021. For investors, the key point is that InnovAge operates a highly integrated care-delivery model that brings together primary care, specialty care coordination, rehabilitation, social services, transportation, pharmacy services, and home-based support under one umbrella, with the core objective of helping seniors remain in their homes and communities for as long as possible. Operationally, InnovAge reports as a single segment, PACE, which underscores management’s strategic focus on one specialized healthcare platform rather than a broad portfolio of business lines. As of June 30, 2025, the company served approximately 7,740 PACE participants, making it the largest PACE provider in the United States by participants served. It also operated 20 PACE centers across California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. That geographic footprint gives InnovAge exposure to multiple regional markets while remaining concentrated in a regulated, niche care-delivery category. Its competitive position is built less on consumer brand power and more on scale within PACE, clinical and regulatory expertise, and the ability to manage complex patient populations efficiently. Recent developments suggest a company that is still focused on execution and governance improvements. In September 2025, InnovAge reported fiscal 2025 results and said the year reflected responsible growth, financial discipline, clinical performance, and compliance execution. In May 2026, the company announced that Jennifer Browne would join as President and Chief Operating Officer, effective June 8, 2026, a notable leadership appointment that may support operational scaling. For investors tracking INNV on the Nasdaq in the United States, the story remains centered on a specialized healthcare platform with meaningful national scale in PACE, balanced against the usual risks of reimbursement, compliance, staffing, and operational execution in a highly regulated care environment.